Eucrisa® (crisaborole) coverage has gone through changes in the past 2 years.
In this episode we will cover only the coverage for UHC Commercial + Oxford policies
Things to take in consideration:
- Eucrisa® (crisaborole) is part of Pharmacy Benefit for UHC Commercial + Oxford policies.
- It is a Step Therapy
- Policy was created in 07/2017 and Updated with no changes on 07/2018
- Effective Date is 10/01/2018
- Authorization is given for 12 months
- If the patient had samples of Eucrisa prior to the provider initiating Prior approval, that patient still needs to meet the Step Therapy requirement
Please look below for reference:
KR2 Medical Billing 